Key facts
- This page summarizes Michael Marinaro's Form 4 filing for Medtronic plc (MDT).
- 7 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 04 Aug 2025, 16:17.
Michael Marinaro - 01 Aug 2025 Form 4 Insider Report for Medtronic plc (MDT)
- Reporting relationship
- EVP, Pres MedSurg and Americas
- Issuer ticker
- MDT
- Reported as of
- 01 Aug 2025
- Net transaction value
- -$449,718
- SEC form
- 4
- Accepted by SEC
- 04 Aug 2025, 16:17:37 UTC
- Prior SEC filing
- 30 Jul 2025
- Next SEC filing
- 21 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patricia Walesiewicz, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Marinaro filed Form 4 for Medtronic plc (MDT) on 04 Aug 2025.
Change
- Previous filing in this sequence was filed on 30 Jul 2025.
- Current net transaction value: -$449,718.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001984186
Primary reporting owner
Marinaro Michael
- Relationship
- EVP, Pres MedSurg and Americas
- Address
- 710 MEDTRONIC PARKWAY, MINNEAPOLIS
- Signature
- /s/ Patricia Walesiewicz, attorney-in-fact
- Signature date
- 04 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDT
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $0
- Shares
- +6,535
- Change %
- +13%
- Price
- $0.000000
- Shares after
- 57,628
- Date
- 01 Aug 2025
- Ownership
- Direct
- Footnotes
- F1
MDT
transaction
Ordinary Shares
Tax liability
- Transaction value
- $282,136
- Shares
- -3,158
- Change %
- -5.5%
- Price
- $89.34
- Shares after
- 54,470
- Date
- 01 Aug 2025
- Ownership
- Direct
- Footnotes
- F2
MDT
transaction
Ordinary Shares
Tax liability
- Transaction value
- $155,541
- Shares
- -1,741
- Change %
- -3.2%
- Price
- $89.34
- Shares after
- 52,729
- Date
- 01 Aug 2025
- Ownership
- Direct
- Footnotes
- F3
MDT
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $243,828
- Shares
- +3,126
- Change %
- +5.9%
- Price
- $78.00
- Shares after
- 55,855
- Date
- 01 Aug 2025
- Ownership
- Direct
MDT
transaction
Ordinary Shares
Tax liability
- Transaction value
- $255,870
- Shares
- -2,864
- Change %
- -5.1%
- Price
- $89.34
- Shares after
- 52,991
- Date
- 01 Aug 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDT
transaction
Derivative
Performance Share Unit
Options Exercise
- Transaction value
- $0
- Shares
- -6,535
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 01 Aug 2025
- Ownership
- Direct
- Underlying class
- Performance Share Units
- Underlying amount
- 6,535
- Exercise price
- Footnotes
- F4, F5
MDT
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,126
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 01 Aug 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 3,126
- Exercise price
- $78.00
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.
Footnote F2
Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.
Footnote F3
Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
Footnote F4
Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
Footnote F5
The performance share units vested on August 1, 2025.
Footnote F6
These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.